Company · CIK 0001636651 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Ovid Therapeutics Inc. · OVID
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 AForm 4 → | Jul 8, 4:31 pm EDT | Charles Ross CarterChief Financial Officer | 50,000 | — | — | 94,375 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.